Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR Inhibitors

SIMPLE SUMMARY: Ovarian cancer (OC) is known for its poor prognosis, due to the absence of reliable biomarkers and its late diagnosis, since the early-stage disease is almost asymptomatic. Lipid metabolism plays an important role in OC progression due to the development of omental metastasis in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacome Sanz, Dafne, Raivola, Juuli, Karvonen, Hanna, Arjama, Mariliina, Barker, Harlan, Murumägi, Astrid, Ungureanu, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345177/
https://www.ncbi.nlm.nih.gov/pubmed/34359627
http://dx.doi.org/10.3390/cancers13153727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345177/
https://www.ncbi.nlm.nih.gov/pubmed/34359627
http://dx.doi.org/10.3390/cancers13153727

Ejemplares similares